Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACM Research, Inc.ACMR · Entity 3926 | Director · See Remarks · 10% owner | September 08, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACM Research, Inc.
Report date September 08, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 802,708 |
Ending reported balance
After 2026-09-09 transaction · row 11
11 source rows · reconciled sequenceRow 1 · 2026-09-08 · Exercise / conversion · Acquired 70,000 · Balance 872,708 Row 2 · 2026-09-08 · Sale · Disposed 4,803 · Balance 867,905 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.52 to $76.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5), (6), (7), (8), (9), and (10) to this Form 4. Row 3 · 2026-09-08 · Sale · Disposed 51,374 · Balance 816,531 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.52 to $77.5, inclusive. Row 4 · 2026-09-08 · Sale · Disposed 12,323 · Balance 804,208 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.52 to $78.48, inclusive. Row 5 · 2026-09-08 · Sale · Disposed 1,500 · Balance 802,708 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.55 to $78.64, inclusive. Row 6 · 2026-09-09 · Exercise / conversion · Acquired 70,000 · Balance 872,708 Row 7 · 2026-09-09 · Sale · Disposed 33,493 · Balance 839,215 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.26 to $74.21, inclusive. Row 8 · 2026-09-09 · Sale · Disposed 18,934 · Balance 820,281 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.26 to $75.22, inclusive. Row 9 · 2026-09-09 · Sale · Disposed 11,666 · Balance 808,615 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.28 to $75.95, inclusive. Row 10 · 2026-09-09 · Sale · Disposed 4,807 · Balance 803,808 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.38 to $77.35, inclusive. Row 11 · 2026-09-09 · Sale · Disposed 1,100 · Balance 802,708 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.59 to $77.59, inclusive. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2026-12-27 | Direct | 200,000 |
Reported balance
After 2026-09-08 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2026-09-08 · Exercise / conversion · Disposed 70,000 · Balance 200,000 F11: The option is fully vested and exercisable. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2026-12-27 | Direct | 130,000 |
Reported balance
After 2026-09-09 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2026-09-09 · Exercise / conversion · Disposed 70,000 · Balance 130,000 F11: The option is fully vested and exercisable. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Jing Chen, wife of David H. Wang | 100,002 |
Reported balance
Holding disclosure · report date 2026-09-08 · row 12
Holding and transaction disclosures are not merged.
1 source rowRow 12 · Balance 100,002 |
| Class A Common StockSEC Table I · non-derivative | IndirectBy David Hui Wang and Jing Chen Family Irrevocable Trust for Wang Children | 180,000 |
Reported balance
Holding disclosure · report date 2026-09-08 · row 13
Holding and transaction disclosures are not merged.
1 source rowRow 13 · Balance 180,000 |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Wang-Chen Family Living Trust | 620,001 |
Reported balance
Holding disclosure · report date 2026-09-08 · row 14
Holding and transaction disclosures are not merged.
1 source rowRow 14 · Balance 620,001 |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.52 to $76.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5), (6), (7), (8), (9), and (10) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.52 to $77.5, inclusive.
F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.52 to $78.48, inclusive.
F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.55 to $78.64, inclusive.
F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.26 to $74.21, inclusive.
F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.26 to $75.22, inclusive.
F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.28 to $75.95, inclusive.
F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.38 to $77.35, inclusive.
F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.59 to $77.59, inclusive.
F11: The option is fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 10, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 70,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001140361-26-036191 · form4.xml · derivative · entry 16 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,000 Underlying: Class A Common Stock · 70,000 shares Expires 2026-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 09, 2026 Filed Sep 10, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 1,100 | $77.59 | $85,349.00 |
DisclosureSEC source: 0001140361-26-036191 · form4.xml · nonDerivative · entry 11 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 802,708 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.59 to $77.59, inclusive. Read SEC document |
| September 09, 2026 Filed Sep 10, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 4,807 | $76.73 | $368,841.11 |
DisclosureSEC source: 0001140361-26-036191 · form4.xml · nonDerivative · entry 10 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 803,808 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.38 to $77.35, inclusive. Read SEC document |
| September 09, 2026 Filed Sep 10, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 11,666 | $75.58 | $881,716.28 |
DisclosureSEC source: 0001140361-26-036191 · form4.xml · nonDerivative · entry 9 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 808,615 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.28 to $75.95, inclusive. Read SEC document |
| September 09, 2026 Filed Sep 10, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 18,934 | $74.67 | $1,413,801.78 |
DisclosureSEC source: 0001140361-26-036191 · form4.xml · nonDerivative · entry 8 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 820,281 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.26 to $75.22, inclusive. Read SEC document |
| September 09, 2026 Filed Sep 10, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 33,493 | $73.80 | $2,471,783.40 |
DisclosureSEC source: 0001140361-26-036191 · form4.xml · nonDerivative · entry 7 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 839,215 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.26 to $74.21, inclusive. Read SEC document |
| September 09, 2026 Filed Sep 10, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 70,000 | $1.00 | $70,000.00 |
DisclosureSEC source: 0001140361-26-036191 · form4.xml · nonDerivative · entry 6 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 872,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 70,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001140361-26-036191 · form4.xml · derivative · entry 15 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200,000 Underlying: Class A Common Stock · 70,000 shares Expires 2026-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 1,500 | $78.57 | $117,855.00 |
DisclosureSEC source: 0001140361-26-036191 · form4.xml · nonDerivative · entry 5 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 802,708 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.55 to $78.64, inclusive. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 12,323 | $78.08 | $962,179.84 |
DisclosureSEC source: 0001140361-26-036191 · form4.xml · nonDerivative · entry 4 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 804,208 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.52 to $78.48, inclusive. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 51,374 | $77.15 | $3,963,504.10 |
DisclosureSEC source: 0001140361-26-036191 · form4.xml · nonDerivative · entry 3 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 816,531 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.52 to $77.5, inclusive. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 4,803 | $75.99 | $364,979.97 |
DisclosureSEC source: 0001140361-26-036191 · form4.xml · nonDerivative · entry 2 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 867,905 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.52 to $76.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5), (6), (7), (8), (9), and (10) to this Form 4. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 70,000 | $1.00 | $70,000.00 |
DisclosureSEC source: 0001140361-26-036191 · form4.xml · nonDerivative · entry 1 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 872,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 40,002 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · derivative · entry 19 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 270,000 Underlying: Class A Common Stock · 40,002 shares Expires 2026-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 826 | $87.91 | $72,613.66 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · nonDerivative · entry 13 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 802,708 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F12 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.77 to $88.01, inclusive. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 8,581 | $87.13 | $747,662.53 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · nonDerivative · entry 12 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 803,534 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.73 to $87.66, inclusive. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 10,992 | $86.07 | $946,081.44 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · nonDerivative · entry 11 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 812,115 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.7 to $86.57, inclusive. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 17,543 | $85.11 | $1,493,084.73 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · nonDerivative · entry 10 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 823,107 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $84.62 to $85.6, inclusive. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 2,060 | $83.86 | $172,751.60 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · nonDerivative · entry 9 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 840,650 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.61 to $84.24, inclusive. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 40,002 | $1.00 | $40,002.00 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · nonDerivative · entry 8 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 842,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 60,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · derivative · entry 18 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 310,002 Underlying: Class A Common Stock · 60,000 shares Expires 2026-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 1,187 | $93.04 | $110,438.48 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · nonDerivative · entry 7 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 802,708 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.02 to $93.39, inclusive. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 5,843 | $92.38 | $539,776.34 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · nonDerivative · entry 6 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 803,895 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.01 to $92.8, inclusive. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 9,925 | $90.78 | $900,991.50 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · nonDerivative · entry 5 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 809,738 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.24 to $91.22, inclusive. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 32,450 | $89.84 | $2,915,308.00 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · nonDerivative · entry 4 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 819,663 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.24 to $90.22, inclusive. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 6,295 | $88.98 | $560,129.10 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · nonDerivative · entry 3 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 852,113 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.24 to $89.22, inclusive. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 4,300 | $87.57 | $376,551.00 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · nonDerivative · entry 2 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 858,408 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.22 to $88.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), and (12) to this Form 4. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 60,000 | $1.00 | $60,000.00 |
DisclosureSEC source: 0001140361-26-024280 · form4.xml · nonDerivative · entry 1 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 862,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2026 Filed Jul 7, 2026 01:00 UTC | ACM Research, Inc. ACMR · Entity 3926 | GrantRestricted Stock Units · Derivative | 6,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-027691 · form4.xml · derivative · entry 5 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Sophia Wang, daughter of David H. Wang Disclosed balance after: 6,208 Underlying: Class A Common Stock · 6,208 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ACMR common stock. F2 · shares: The number of RSUs granted will be determined by dividing the applicable annual grant value by the 30-day lookback average fair market value of the Issuer's common stock, determined to be $51.54 per share. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning May 13, 2027. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning May 13, 2027. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 20:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 50,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001140361-26-009401 · form4.xml · derivative · entry 13 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 370,002 Underlying: Class A Common Stock · 50,000 shares Expires 2026-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 20:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 702 | $46.57 | $32,692.14 |
DisclosureSEC source: 0001140361-26-009401 · form4.xml · nonDerivative · entry 7 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 802,708 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.45 to $46.59, inclusive. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 20:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 38,737 | $45.74 | $1,771,830.38 |
DisclosureSEC source: 0001140361-26-009401 · form4.xml · nonDerivative · entry 6 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 803,410 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.40 to $46.39, inclusive. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 20:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 10,561 | $44.92 | $474,400.12 |
DisclosureSEC source: 0001140361-26-009401 · form4.xml · nonDerivative · entry 5 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 842,147 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.40 to $45.39, inclusive. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 20:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 50,000 | $1.00 | $50,000.00 |
DisclosureSEC source: 0001140361-26-009401 · form4.xml · nonDerivative · entry 4 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 852,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 60,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001140361-26-009401 · form4.xml · derivative · entry 12 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 420,002 Underlying: Class A Common Stock · 60,000 shares Expires 2026-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 4,627 | $48.34 | $223,669.18 |
DisclosureSEC source: 0001140361-26-009401 · form4.xml · nonDerivative · entry 3 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 802,708 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.23 to $48.61, inclusive. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 55,373 | $47.89 | $2,651,812.97 |
DisclosureSEC source: 0001140361-26-009401 · form4.xml · nonDerivative · entry 2 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 807,335 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.23 to $48.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5), and (6) to this Form 4. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:46 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 60,000 | $1.00 | $60,000.00 |
DisclosureSEC source: 0001140361-26-009401 · form4.xml · nonDerivative · entry 1 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 862,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | GrantStock Option · Derivative | 545,400 | $0.00 Strike: $7.36 | $0.00 |
DisclosureSEC source: 0001140361-26-004200 · form4.xml · derivative · entry 5 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,636,197 Underlying: Class A Common Stock · 545,400 shares Expires 2030-03-19 F1 · derivative.exercise_date: On March 20, 2020, the reporting person was granted options to purchase an aggregate of 1,636,197 shares of the Issuer's Class A common stock, based on the satisfaction of certain performance criteria. In general, one-third of the shares subject to the options vest and become exercisable upon an increase in the Issuer's market capitalization (calculated as described in footnote 2) of $1 billion, $2 billion and $3 billion, respectively, from the market capitalization of $553,383,586 on the date of grant. 545,400 shares vested and became exercisable on February 4, 2026, which was the first trading day as of which the Issuer's market capitalization equaled or exceeded $3,553,383,586. F2 · derivative.exercise_date: For purposes of the options, the market capitalization as of a specified trading day is calculated by multiplying (a) the average of the daily volume-weighted average price per share of the Issuer's Class A common stock for each of the trading days occurring during the thirty calendar day period ending on that specified trading day by (b) the total number of issued and outstanding shares of the Issuer's Class A and Class B common stock as of 11:59 p.m. (Eastern time) on such specified trading day. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 60,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001140361-25-044559 · form4.xml · derivative · entry 12 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 480,002 Underlying: Class A Common Stock · 60,000 shares Expires 2026-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 40,183 | $34.42 | $1,383,098.86 |
DisclosureSEC source: 0001140361-25-044559 · form4.xml · nonDerivative · entry 6 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 802,708 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.18 to $34.63, inclusive. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 19,817 | $33.52 | $664,265.84 |
DisclosureSEC source: 0001140361-25-044559 · form4.xml · nonDerivative · entry 5 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 842,891 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.07 to $34.04, inclusive. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 60,000 | $1.00 | $60,000.00 |
DisclosureSEC source: 0001140361-25-044559 · form4.xml · nonDerivative · entry 4 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 862,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 70,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001140361-25-044559 · form4.xml · derivative · entry 11 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 540,002 Underlying: Class A Common Stock · 70,000 shares Expires 2026-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 1,200 | $33.56 | $40,272.00 |
DisclosureSEC source: 0001140361-25-044559 · form4.xml · nonDerivative · entry 3 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 802,708 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.53 to $33.59, inclusive. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | SaleClass A Common Stock | 68,800 | $33.05 | $2,273,840.00 |
DisclosureSEC source: 0001140361-25-044559 · form4.xml · nonDerivative · entry 2 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 803,908 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2024. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.51 to $33.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), and (5) to this Form 4. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 21:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 70,000 | $1.00 | $70,000.00 |
DisclosureSEC source: 0001140361-25-044559 · form4.xml · nonDerivative · entry 1 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 872,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2025 Filed Oct 30, 2025 01:30 UTC | ACM Research, Inc. ACMR · Entity 3926 | GrantStock Option · Derivative | 545,400 | $0.00 Strike: $7.36 | $0.00 |
DisclosureSEC source: 0001140361-25-039758 · form4.xml · derivative · entry 5 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 545,400 Underlying: Class A Common Stock · 545,400 shares Expires 2030-03-19 F1 · derivative.exercise_date: On March 20, 2020, the reporting person was granted options to purchase an aggregate of 1,636,197 shares of the Issuer's Class A common stock, based on the satisfaction of certain performance criteria. In general, one-third of the shares subject to the options vest and become exercisable upon an increase in the Issuer's market capitalization (calculated as described in footnote 2) of $1 billion, $2 billion and $3 billion, respectively, from the market capitalization of $553,383,586 on the date of grant. 545,400 shares vested and became exercisable on October 27, 2025, which was the first trading day as of which the Issuer's market capitalization equaled or exceeded $2,553,383,586. The remaining shares will vest and become exercise upon the first trading days, if any, on which the Issuer's market capitalization equals or exceeds $3,553,383,586. F2 · derivative.exercise_date: For purposes of the options, the market capitalization as of a specified trading day is calculated by multiplying (a) the average of the daily volume-weighted average price per share of the Issuer's Class A common stock for each of the trading days occurring during the thirty calendar day period ending on that specified trading day by (b) the total number of issued and outstanding shares of the Issuer's Class A and Class B common stock as of 11:59 p.m. (Eastern time) on such specified trading day. Read SEC document |
| September 08, 2025 Filed Oct 1, 2025 01:33 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionStock Option · Derivative | 130,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001140361-25-036835 · form4.xml · derivative · entry 6 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 610,002 Underlying: Class A Common Stock · 130,000 shares Expires 2026-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On September 8, 2025, the reporting person exercised, by net exercise, a previously issued stock option to purchase 130,000 shares of Class A Common Stock of the Issuer. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 08, 2025 Filed Oct 1, 2025 01:33 UTC | ACM Research, Inc. ACMR · Entity 3926 | Exercise / conversionClass A Common Stock | 130,000 | $1.00 | $130,000.00 |
DisclosureSEC source: 0001140361-25-036835 · form4.xml · nonDerivative · entry 1 Wang David H · CIK 0001721580 · Director · See Remarks · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 802,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On September 8, 2025, the reporting person exercised, by net exercise, a previously issued stock option to purchase 130,000 shares of Class A Common Stock of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.